Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Tailleux

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
The Journal of Biological Chemistry|October 26, 2000
Peroxisome proliferator-activated receptor alpha is not rate-limiting for the lipoprotein-lowering action of fish oilJ Dallongeville, E Baugé, A Tailleux, et al.
The Journal of Biological Chemistry|September 8, 2001
Improved lipid and lipoprotein profile, hepatic insulin sensitivity, and glucose tolerance in 11beta-hydroxysteroid dehydrogenase type 1 null miceN M Morton, M C Holmes, C Fiévet, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|July 20, 2000
Absence of relationship between plasma Lp(a), Lp-AI, anti-oxidized LDL autoantibodies, LDL immune complexes concentrations and restenosis after percutaneous transluminal coronary angioplastyA Boullier, E Walters-Laporte, M Hamon, et al.
European Journal of Biochemistry|June 1, 1995
Tissue-specific expression of the human gene for lecithin: cholesterol acyltransferase in transgenic mice alters blood lipids, lipoproteins and lipases towards a less atherogenic profileA Mehlum, B Staels, N Duverger, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 14, 2000
Decreased susceptibility to diet-induced atherosclerosis in human apolipoprotein A-II transgenic miceA Tailleux, M Bouly, G Luc, et al.
Gene|April 24, 1995
A 700-bp fragment of the human antithrombin III promoter is sufficient to confer high, tissue-specific expression on human apolipoprotein A-II in transgenic miceG L Tremp, N Duchange, D Branellec, et al.
Clinical Science (London, England : 1979)|February 27, 2001
Increased levels of high-density lipoprotein cholesterol are ineffective in inhibiting the development of immune responses to oxidized low-density lipoprotein and atherosclerosis in transgenic rabbits expressing human apolipoprotein (apo) A-I with severe hypercholesterolaemiaA Boullier, N Hennuyer, A Tailleux, et al.
Biochemical and Biophysical Research Communications|February 12, 1998
Endothelial derived vasorelaxation is impaired in human APO A-I transgenic rabbitsG Lebuffe, A Boullier, A Tailleux, et al.
Circulation|August 15, 1996
Inhibition of atherosclerosis development in cholesterol-fed human apolipoprotein A-I-transgenic rabbitsN Duverger, H Kruth, F Emmanuel, et al.
Biochemistry|February 25, 1997
Cholesterol efflux, lecithin-cholesterol acyltransferase activity, and pre-beta particle formation by serum from human apolipoprotein A-I and apolipoprotein A-I/apolipoprotein A-II transgenic mice consistent with the latter being less effective for reverse cholesterol transportG Castro, L P Nihoul, C Dengremont, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
The Journal of Biological Chemistry|October 26, 2000
Peroxisome proliferator-activated receptor alpha is not rate-limiting for the lipoprotein-lowering action of fish oilJ Dallongeville, E Baugé, A Tailleux, et al.
The Journal of Biological Chemistry|September 8, 2001
Improved lipid and lipoprotein profile, hepatic insulin sensitivity, and glucose tolerance in 11beta-hydroxysteroid dehydrogenase type 1 null miceN M Morton, M C Holmes, C Fiévet, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|July 20, 2000
Absence of relationship between plasma Lp(a), Lp-AI, anti-oxidized LDL autoantibodies, LDL immune complexes concentrations and restenosis after percutaneous transluminal coronary angioplastyA Boullier, E Walters-Laporte, M Hamon, et al.
European Journal of Biochemistry|June 1, 1995
Tissue-specific expression of the human gene for lecithin: cholesterol acyltransferase in transgenic mice alters blood lipids, lipoproteins and lipases towards a less atherogenic profileA Mehlum, B Staels, N Duverger, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 14, 2000
Decreased susceptibility to diet-induced atherosclerosis in human apolipoprotein A-II transgenic miceA Tailleux, M Bouly, G Luc, et al.
Gene|April 24, 1995
A 700-bp fragment of the human antithrombin III promoter is sufficient to confer high, tissue-specific expression on human apolipoprotein A-II in transgenic miceG L Tremp, N Duchange, D Branellec, et al.
Clinical Science (London, England : 1979)|February 27, 2001
Increased levels of high-density lipoprotein cholesterol are ineffective in inhibiting the development of immune responses to oxidized low-density lipoprotein and atherosclerosis in transgenic rabbits expressing human apolipoprotein (apo) A-I with severe hypercholesterolaemiaA Boullier, N Hennuyer, A Tailleux, et al.
Biochemical and Biophysical Research Communications|February 12, 1998
Endothelial derived vasorelaxation is impaired in human APO A-I transgenic rabbitsG Lebuffe, A Boullier, A Tailleux, et al.
Circulation|August 15, 1996
Inhibition of atherosclerosis development in cholesterol-fed human apolipoprotein A-I-transgenic rabbitsN Duverger, H Kruth, F Emmanuel, et al.
Biochemistry|February 25, 1997
Cholesterol efflux, lecithin-cholesterol acyltransferase activity, and pre-beta particle formation by serum from human apolipoprotein A-I and apolipoprotein A-I/apolipoprotein A-II transgenic mice consistent with the latter being less effective for reverse cholesterol transportG Castro, L P Nihoul, C Dengremont, et al.
Pageof 3